Skip to search.
 TSX Down 1.30% TSX Ventures Down 1.82%

Pluristem Therapeutics, Inc. (PSTI)

-NasdaqCM
2.37 Up 0.08(3.49%) Jul 27, 4:00PM EDT
Add to Portfolio
Prev Close:2.29
Open:2.38
Bid:2.43 x 200
Ask:2.45 x 100
1y Target Est:5.50
Beta:-1.16
Next Earnings Date:N/A
Day's Range:2.34 - 2.38
52wk Range:2.27 - 3.78
Volume:151,846
Avg Vol (3m):177,063
Market Cap:186.05M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
PSTIUp 3.49%186.05M
ASTM 0.00%N/A
ACTC 0.00%N/A
OSIR 0.00%746.95M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):430.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.38
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related tech... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback